Analytical Data
-
基因名
LDOC1
- Application
-
别名
LDOC1;BCUR1;Protein LDOC1
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
O95751
-
表达区间
1-146aa
-
氨基酸序列
MVDELVLLLH ALLMRHRALS IENSQLMEQL RLLVCERASL LRQVRPPSCP VPFPETFNGE SSRLPEFIVQ TASYMLVNEN RFCNDAMKVA FLISLLTGEA EEWVVPYIEM DSPILGDYRA FLDEMKQCFG WDDDEDDDDE EEEDDY
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
LDOC1, or Lymphocyte Excitation Antigen 1, is a protein implicated in various cellular processes, including immune response and cell signaling. Research into LDOC1 has gained traction due to its potential role in modulating T-cell function, influencing cytokine production, and its involvement in the pathogenesis of several diseases, including cancer and autoimmune disorders. Given its significance, scientists have focused on the recombinant expression of LDOC1 to facilitate in-depth structural and functional analyses. Recombinant LDOC1 proteins provide a valuable tool for exploring its biological activities and interactions with other molecules. Understanding LDOC1's structure and mechanism is crucial for developing targeted therapies that can manipulate its functions, potentially leading to innovative treatments for diseases where LDOC1 is implicated. Recent advancements in biotechnology techniques, such as CRISPR and protein engineering, have further enabled researchers to study LDOC1 in greater detail, paving the way for novel therapeutic strategies that could leverage its immunological properties. As research progresses, the insights gained from LDOC1 studies could significantly contribute to the fields of immunology and therapeutic development, highlighting the importance of continued exploration of this protein's biological potential.
